Abstract
Depression is a cause of increasing concern worldwide. During the 20th century, striking changes occurred in the epidemiology of major depression, including a marked increase in lifetime risk (Cross-National Collaborative Group, 1992) and a decreased age of onset (Klerman, 1988; Klerman & Weissman, 1988). This has coincided with well-documented similarly striking changes in dietary fatty acid intake, particularly in the western world, including a move to more highly saturated fats than polyunsaturated fats and, within the polyunsaturated fat intake, a move away from n-3 fatty acids to n-6 fatty acids (particularly linoleic acid) (Eaton & Kanner, 1985; Lands, 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, P. B., Lawson, S., Sanigorski, A. & Sinclair, A. J. (1996). Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids, 31 (Suppl), S157–S161.
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., Rev.) (DSM-III-R), Washington, DC: American Psychiatric Association.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.) (DSM-IV), Washington, DC: American Psychiatric Association.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Rev.) (DSM-IV-TR), Washington, DC: American Psychiatric Association.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1981). An inventory for measuring depression. Archives of General Psychiatry, 38, 147–150.
Bydder, G. M. (1995). The Mackenzie Davidson Memorial Lecture: Detection of small changes to the brain with serial magnetic resonance imaging. British Journal of Radiology, 68, 1271–1295.
Bydder, G. M., & Hajnal, J. V. (1997a). Registration and subtraction of serial MRI—Part 2: Image interpretation. In W. G. Bradley & G. M. Bydder (Eds.) Advanced MR imaging techniques (pp. 239–258). London: Martin Dunitz.
Bydder, G. M., & Hajnal, J. V. (1997b). Registration and subtraction of serial MRI—Part 3: Applications. In W. G. Bradley & G. M. Bydder (Eds.) Advanced MR imaging techniques (pp. 259–280). London: Martin Dunitz.
Carroll, B. J. (1982). The dexamethasone suppression test for melancholia. British Journal of Psychiatry, 140, 292–304.
Cross-National Collaborative Group. (1992). The changing rate of major depression. Journal of the American Medical Association, 268, 3098–3105.
De Vriese, S. R., Christophe, A. B., & Maes, M. (2004). In humans, the seasonal variation in poly-unsaturated fatty acids is related to the seasonal variation in violent suicide and serotonergic markers of violent suicide. Prostaglandins, Leukotrienes and Essential Fatty Acids, 71, 13–18.
Eaton, S. B., & Kanner, M. (1985). Paleolithic nutrition. New England Journal of Medicine, 312, 283–289.
Edwards, R., Peet, M., Shay, J., & Horrobin, D. (1998). Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. Journal of Affective Disorders, 48, 149–155.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Heron, D. S., Shinitzky, M., Hershkowitz, M., & Samuel, D. (1980). Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proceedings of the National Academy of Sciences of the USA, 77, 7463–7467.
Hibbeln, J.R. (1998). Fish consumption and major depression. Lancet, 351, 1213.
Horrobin, D. F., & Bennett, C. N. (2003) Phospholipid metabolism and the pathophysiology of psychiatric and neurological disorders. In M. Peet, I. Glen, & D. F. Horrobin (Eds.), Phospholipid spectrum disorder in psychiatry and neurology, (2nd ed., pp. 3–47). Carnforth, Lancashire: Marius.
Kim, Y. K., Suh, I. B., Kim, H., Han, C. S., Lim, C. S., Choi, S. H., & Licinio, J. (2002). The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs. Molecular Psychiatry, 7, 1107–1114.
Klerman, G. L. (1988). The current age of youthful melancholia. British Journal of Psychiatry, 152, 4–14.
Klerman, G. L., & Weissman, M. M. (1988). Increasing rates of depression. Journal of the American Medical Association, 261, 2229–2235.
Lands, W. E. (1992). Biochemistry and physiology of n-3 fatty acids. Federation of American Societies for Experimental Biology Journal, 6, 2530–2536.
Maes, M., Cosyns, P., Meltzer, H. Y., De Meyer, F, & Peeters, D. (1993a). Seasonality in violent suicide but not in nonviolent suicide or homicide. American Journal of Psychiatry, 150, 1380–1385.
Maes, M., Meltzer, H. Y., Suy, E., & De Meyer, F. (1993b). Seasonality in severity of depression: Relationships to suicide and homicide occurrence. Acta Psychiatrica Scandinavica, 88, 156–161.
Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., & Meltzer, H. (1996). Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders, 38, 35–46.
Montgomery, S. A., & & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Muller, M. B., Keck, M. E., Binder, E. B., Kresse, A. E., Hagemeyer, T. P., Landgraf, R., Holsboer, F., & Uhr, M. (1993). ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: Implications for affective disorder. Neuropsychopharmacology, 28, 1991–1999.
Nemets, B., Stahl, Z., & Belmaker, R.H. (2002). Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry, 159, 477–479.
Peet, M., & Bennett, C. N. (2003). Relationship between brain lipids, depression and suicide. In M. Peet, I. Glen, & P. F. Horrobin (Eds.), Phospholipid spectrum disorder in psychiatry and neurology (2nd ed., pp. 403–408). Carnforth, Lancashire: Marius.
Peet, M., & Horrobin, D. F. (2002). A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry, 59, 913–919.
Peet, M., Murphy, B., Shay, J., & Horrobin, D. (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry, 43, 315–319.
Pettegrew, J. W., Keshavan, M. S., Panchalingam, K., Strychor, S., Kaplan, D. B., Tretta, M. G., & Allen, M. (1991). Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Archives of General Psychiatry, 48, 563–568.
Puri, B. K. (2003). Niacin testing in other psychiatric and neurological disorders. In Phospholipid spectrum disorder in psychiatry and neurology (2nd ed., pp. 353–356). Carnforth, Lancashire: Marius.
Puri, B. K. (2004). Monomodal rigid-body registration and applications to the investigation of the effects of eicosapentaenoic acid intervention in neuropsychiatric disorders. Prostaglandins, Leukotrienes and Essential Fatty Acids, 71, 177–179.
Puri, B. K., Counsell, S. J., Hamilton, G., Richardson, A. J., & Horrobin, D. F. (2001). Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. International Journal of Clinical Practice, 55, 560–563.
Puri, B. K., Counsell, S. J., Richardson, A. J., & Horrobin, D. F. (2002a). Eicosapentaenoic acid in treatment-resistant depression. Archives of General Psychiatry, 59, 91–92.
Puri, B. K., Hirsch, S. R., Easton, T., & Richardson, A. J. (2002b). A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry, 26, 49–52.
Ratnasinghe, D., Daschner, P. J., Anver, M. R., Kasprzak, B. H., Taylor, P. R., Yeh, G. C., & Tangrea, J. A. (2001). Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? Anticancer Research, 21, 2141–2147.
Rush, A. J., Giles, D. E., Schlesser, M. A., Orsulak, P. J., Parker, C. R. Jr, Weissenburger, J. E., Crowley, G. T., Khatami, M., & Vasavada, N. (1996). The dexamethasone suppression test in patients with mood disorders. Journal of Clinical Psychiatry, 57, 470–484.
Su, K. P., Huang, S. Y., Chiu, C. C., & Shen, W. W. (2003). Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology, 13, 267–271.
Ward, P. E., Sutherland, J., Glen, E. M., & Glen, A. I. (1998). Niacin skin flush in schizophrenia: A preliminary report. Schizophrenia Research, 29, 269–274.
Weissman, M. M., Bland, R. C., Canino, G. J., Faravelli, C., Greenwald, S., Hwu, H. G., Joyce, P. R., Karam, E. G., Lee, C. K., Lellouch, J., Lepine, J. P., Newman, S. C., Rubio-Stipec, M., Wells, J. E., Wickramaratne, P. J., Wittchen, H., & Yeh, E. K. (1993). Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association, 276, 293–299.
Ziemann, C., Schafer, D., Rudell, G., Kahl, G. F., & Hirsch-Ernst, K. I. (2002). The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures. Hepatology, 35, 579–588.
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001). The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain, Behavior, and Immunity, 15, 199–226.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Puri, B.K. (2006). Lipids and Depression. In: Yehuda, S., Mostofsky, D.I. (eds) Nutrients, Stress, and Medical Disorders. Nutrition and Health. Humana Press. https://doi.org/10.1385/1-59259-952-4:221
Download citation
DOI: https://doi.org/10.1385/1-59259-952-4:221
Publisher Name: Humana Press
Print ISBN: 978-1-58829-432-6
Online ISBN: 978-1-59259-952-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)